Caroline Dorsa bought stock once, on May 2, 2025

Caroline Dorsa is a corporate director and former Chair of the Board of Directors of Biogen Inc. (NASDAQ: BIIB), where she has served as a director since 2010.( She was elected Chair effective immediately following Biogen’s 2023 Annual Meeting of Stockholders, succeeding Stelios Papadopoulos, and later announced her intention to retire from the board and not stand for reelection at the company’s 2026 Annual Meeting.( In her role at Biogen, Dorsa has overseen board-level governance and strategy at a leading global biotechnology company focused on neurological and neurodegenerative diseases.(

Before joining Biogen’s board, Dorsa built a long career in finance and operations across the pharmaceutical and energy sectors.( She served as Executive Vice President and Chief Financial Officer of Public Service Enterprise Group (PSEG), a diversified energy company, from 2009 until her retirement in 2015, and was a member of PSEG’s board from 2003 to 2009.( Earlier, she spent 21 years at Merck & Co., holding senior roles including Senior Vice President, Global Human Health, Strategy and Integration, and Vice President and Treasurer.( Her experience also includes serving as Senior Vice President and Chief Financial Officer at Avaya Inc. and Gilead Sciences Inc., as well as early-career work in economic development for the City of New York under Mayor Ed Koch.( Dorsa holds a B.A. from Colgate University and an M.B.A. from Columbia Business School, underpinning her extensive leadership in corporate finance and strategic management.(

Written by Perplexity from public sources.